62 related articles for article (PubMed ID: 7781957)
1. [Portal hypertension: value of combination of nitrate derivatives and beta blockers for better prevention?].
Oberti F; Calès P
Gastroenterol Clin Biol; 1995 Mar; 19(3):328-31. PubMed ID: 7781957
[No Abstract] [Full Text] [Related]
2. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
[TBL] [Abstract][Full Text] [Related]
3. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
Vorob'ev LP; Maev IV; Andreev NG
Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
[TBL] [Abstract][Full Text] [Related]
4. Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin.
Hallemans R; Naeije R; Mols P; Mélot C; Reding P
Crit Care Med; 1983 Jul; 11(7):536-40. PubMed ID: 6861502
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of propranolol versus propranolol plus isosorbide 5-mononitrate in portal hypertension in cirrhotics. Evaluating splanchnic hemodynamics with color Doppler ultrasound].
Sánchez del Monte J; Ramos Gómez MV; Velazquez Ochoa E
Rev Gastroenterol Mex; 2005; 70(3):261-8. PubMed ID: 17063781
[TBL] [Abstract][Full Text] [Related]
6. Isosorbide dinitrate in portal hypertensive patients.
Vorobioff J; Picabea E; Gamen M; Villavicencio R
J Hepatol; 1992 Nov; 16(3):387. PubMed ID: 1487620
[No Abstract] [Full Text] [Related]
7. [Cirrhotic cardiomyopathy: prolonged QTc-interval and dyssynchronic electrical and mechanical systole in cirrhosis].
Henriksen JH; Fuglsang S; Bendtsen F; Christensen E; Møller S
Ugeskr Laeger; 2004 Aug; 166(35):2995-8. PubMed ID: 15387011
[No Abstract] [Full Text] [Related]
8. Management of portal hypertension and esophageal varices in alcoholic cirrhosis.
Trevillyan J; Carroll PJ
Am Fam Physician; 1997 Apr; 55(5):1851-8, 1861-2. PubMed ID: 9105210
[TBL] [Abstract][Full Text] [Related]
9. Propranolol: its role in the management of portal hypertension. The ACG Committee on FDA related matters.
Gitlin N
Am J Gastroenterol; 1983 Feb; 78(2):124-6. PubMed ID: 6823937
[No Abstract] [Full Text] [Related]
10. Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly.
Groszmann RJ
Gastroenterology; 1997 Nov; 113(5):1794-7. PubMed ID: 9352888
[No Abstract] [Full Text] [Related]
11. [Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].
Lazebnik LB; Mikheeva OM; Toporkov AS; Komissarenko IA; Vasnev OS; Fedulenkova LV
Eksp Klin Gastroenterol; 2007; (5):57-66. PubMed ID: 18389599
[No Abstract] [Full Text] [Related]
12. Beta-blockers in the prevention of gastrointestinal bleeding.
Lebrec L
Rev Invest Clin; 1990 Jul; 42 Suppl():159-64. PubMed ID: 19256157
[TBL] [Abstract][Full Text] [Related]
13. [PGA index: a way to screen for portal hypertension in an asymptomatic alcoholic patient].
Latrive JP; Barbare JC; Bonnard P; Messerschmitt C; Diab G; Rhein C
Gastroenterol Clin Biol; 1998 Nov; 22(11):977-9. PubMed ID: 9881283
[No Abstract] [Full Text] [Related]
14. Effect of sublingual isosorbide dinitrate on wedged hepatic venous pressure in cirrhotics with portal hypertension.
Qureshi H; Zuberi SJ; Faruqui A
Indian J Gastroenterol; 1988 Jul; 7(3):161-2. PubMed ID: 3397139
[No Abstract] [Full Text] [Related]
15. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
Wlazłowski R; Kruszyński G; Goch JH
Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
[TBL] [Abstract][Full Text] [Related]
16. Portal hypertensive gastropathy: treatment with corticosteroids.
Cremers MI; Oliveira AP; Alves AL; Freitas J
Endoscopy; 2002 Feb; 34(2):177. PubMed ID: 11822018
[No Abstract] [Full Text] [Related]
17. [Drug treatment for portal hypertension due to cirrhosis].
Lebrec D; Benhamou JP
Gastroenterol Clin Biol; 1982; 6(6-7):542-8. PubMed ID: 6126417
[No Abstract] [Full Text] [Related]
18. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
19. [Detection of umbilical vein repatency by Doppler ultrasonics in portal hypertension caused by alcoholic cirrhosis].
Duvauferrier R; Lucas J; Bellossi A; Bretagne JF; Gastard J
Gastroenterol Clin Biol; 1979; 3(8-9):695. PubMed ID: 510864
[No Abstract] [Full Text] [Related]
20. Long term effects of propranolol on portal pressure in cirrhotic patients.
Orban-Schiopu AM; Popescu CR
Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
